Evaluating twenty-years of follow-up after orthotopic liver transplantation, best practice for donor-recipient matching: What can we learn from the past era?

Table 3 Pretransplant renal function n (%)

	20-yr survivors n = 155	20-yr non-survivors n = 140	P
eGFR > 60	126 (80%)	112 (79%)	0.860
MIRF	31 (20%)	29 (21%)	0.879
SIRF	7 (4.5%)	4 (2.9%)	0.453
eGFR 30-39	10 (6.5%)	5 (3.6%)	0.261
eGFR 40-49	8 (5.2%)	7 (5.0%)	0.950
eGFR 50-59	8 (5.2%)	13 (9.3%)	0.169
eGFR 60-69	10 (6.5%)	28 (20%)	0.001
eGFR 70-79	10 (6.5%)	22 (15.7%)	0.011
eGFR 80-89	22 (14.2%)	13 (9.3%)	0.193
eGFR 90-99	16 (10.3%)	14 (10.0%)	0.927
eGFR 100-109	15 (9.7%)	9 (6.4%)	0.308
eGFR 110-119	10 (6.5%)	7 (5.0%)	0.593
eGFR > 120	47 (30.3%)	28 (20.0%)	0.042

LT: Liver transplantation; eGFR: Estimated glomerular filtration rate; MIRF: Moderately impaired renal function; SIRF: Severely impaired renal function.